Published in Heart on June 01, 2004
The diagnosis and treatment of hypertrophic cardiomyopathy. Dtsch Arztebl Int (2011) 0.84
Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy. Clin Interv Aging (2017) 0.75
Increasing evidence for the safety and efficacy of alcohol septal ablation during medium- and long-term follow-up. Clin Res Cardiol (2007) 0.75
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978) 20.37
The management of hypertrophic cardiomyopathy. N Engl J Med (1997) 4.15
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation (1997) 4.09
Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet (1995) 3.67
Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation (1995) 3.20
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J (1997) 2.52
Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J (1999) 2.49
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation (1998) 2.37
Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis (1985) 2.21
Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation (2000) 2.12
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96
Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity): A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc (1988) 1.87
To ablate or operate? that is the question! J Am Coll Cardiol (2001) 1.81
Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med (1985) 1.60
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation (1998) 1.54
Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. J Am Coll Cardiol (1998) 1.47
'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy. Eur Heart J (2002) 1.41
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol (2001) 1.19
Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. Circulation (1989) 1.12
Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg (1996) 1.06
Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J (1983) 1.01
Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1992) 0.97
Management of symptomatic hypertrophic obstructive cardiomyopathy--long-term results after surgical therapy. Thorac Cardiovasc Surg (1999) 0.93
Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation (2001) 0.92
Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J (1983) 0.90
Idiopathic hypertrophic subaortic stenosis in the elderly. N Engl J Med (1971) 0.88
Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol (1999) 0.86
Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol (1990) 0.84
Hypertrophic cardiomyopathy in the aged. Am Heart J (1978) 0.83
Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol (2001) 0.82
Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol (1989) 0.81
Hypertrophic cardiomyopathy--the benefits of a multidisciplinary approach. N Engl J Med (2002) 0.78
New interventions for obstructive hypertrophic cardiomyopathy: promise and prudence. Eur Heart J (1999) 0.78
Idiopathic hypertrophic subaortic stenosis as observed in a large community hospital: relation to age and history of hypertension. J Am Geriatr Soc (1979) 0.78
Hypertrophic and restrictive cardiomyopathies in the elderly. Cardiol Clin (1999) 0.78
Comparison of clinical features in patients greater than or equal to 60 years of age to those less than or equal to 40 years of age with hypertrophic cardiomyopathy. Am J Cardiol (1990) 0.77
Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol (2000) 0.77
Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J (1999) 2.49
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (1989) 2.46
Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sci U S A (1992) 2.22
Left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: increase in gradient after exercise. J Am Coll Cardiol (1992) 2.06
Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension (1990) 1.58
Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy. Z Kardiol (2004) 1.55
Factors influencing breath condensate volume. Pneumologie (2001) 1.51
Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass. J Thorac Cardiovasc Surg (1993) 1.42
[Heart muscle biopsy in dilated cardiomyopathy]. Internist (Berl) (2006) 1.41
'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy. Eur Heart J (2002) 1.41
Prognosis and possible presymptomatic manifestations of congestive cardiomyopathy (COCM). Postgrad Med J (1978) 1.28
Peptide nucleic acid-assisted topological labeling of duplex dna. Methods (2001) 1.11
Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. Arteriosclerosis (1990) 1.06
Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension (1991) 1.04
Model consideration for the origin of life. Environmental structure as stimulus for the evolution of chemical systems. Naturwissenschaften (1976) 1.01
[Joint endoprosthesis pathology. Histopathological diagnostics and classification]. Pathologe (2011) 1.00
[Diagnostic and prognostic value of endomyocardial biopsy in patients with congestive cardiomyopathy (author's transl)]rdiomyopathy(author. Dtsch Med Wochenschr (1975) 1.00
Photoelectric effects in bimolecular lipid-dye membranes. Biochim Biophys Acta (1972) 0.99
DNA content and DNA synthesis in the myocardium of rats after induced renal hypertension. Cardiovasc Res (1974) 0.97
The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol (1990) 0.96
N-terminal amino acid sequence of Bacillus licheniformis alpha-amylase: comparison with Bacillus amyloliquefaciens and Bacillus subtilis Enzymes. J Bacteriol (1982) 0.96
Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice. J Rheumatol (1994) 0.96
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer. Eur Respir J (2004) 0.95
The Biostack experiment on Apollo 16. Life Sci Space Res (1973) 0.95
BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer. Eur Respir J (2002) 0.94
The definition of heart failure. Eur Heart J (1983) 0.94
Self-organization of molecular systems and evolution of the genetic apparatus. Angew Chem Int Ed Engl (1972) 0.94
Exercise performance in hypertrophic cardiomyopathies. Eur Heart J (1983) 0.93
Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural, and immunohistochemical studies. Am J Clin Pathol (1986) 0.92
Arrhythmias in hypertrophic obstructive and non-obstructive cardiomyopathy. Eur Heart J (1983) 0.91
Surgical aspects of typical subaortic and atypical midventricular hypertrophic obstructive cardiomyopathy (HOCM). Thorac Cardiovasc Surg (1981) 0.90
Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J (1983) 0.90
Utility of endomyocardial biopsy guided by delayed enhancement areas on magnetic resonance imaging in the diagnosis of cardiac sarcoidosis. Clin Res Cardiol (2007) 0.89
Decreases of vascular hypertrophy in four different types of arteries in spontaneously hypertensive rats. Am J Med (1989) 0.89
Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine. Br J Pharmacol (1973) 0.89
[The etiology, course and prognosis of dilated cardiomyopathy]. Z Kardiol (1982) 0.89
Inverse regulation of lipid-peroxidizing and hydroperoxyl lipid-reducing enzymes by interleukins 4 and 13. FASEB J (1999) 0.89
[Differential diagnosis of cyanosis. Familial methemoglobin-reductase deficiency]. Med Welt (1971) 0.89
Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol (2005) 0.88
Mid-systolic septal deceleration. A new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography. Z Kardiol (2003) 0.88
Structural basis for lipoxygenase specificity. Conversion of the human leukocyte 5-lipoxygenase to a 15-lipoxygenating enzyme species by site-directed mutagenesis. J Biol Chem (2001) 0.88
[Familial amyloid polyneuropathy of the Portuguese type. Occurrence in a kindred settled in southern Hessen]. Nervenarzt (1975) 0.87
[Effect of alcohol on the heart including alcoholic cardiomyopathy]. Internist (Berl) (1978) 0.87
Current clinical aspects of bacterial endocarditis in infancy, childhood, and adolescence. Eur J Pediatr (1983) 0.87
The integrin alpha IIb-beta 3, platelet glycoprotein IIb-IIIa, can form a functionally active heterodimer complex without the cysteine-rich repeats of the beta 3 subunit. J Biol Chem (1994) 0.87
[Significance of electrocardiography in the diagnosis and course observation of patients with congestive cardiomyopathy]. Z Kardiol (1974) 0.86
[Course observations of hypertrophic obstructive myocardiopathy]. Z Kardiol (1976) 0.86
Proceedings: The recovery of vascular adrenergic nerve function in the rat after chemical sympathectomy with 6-hydroxydopamine. Br J Pharmacol (1972) 0.86
Autoradiographic evidence for penetration of 3H-ceftriaxone (Rocephin) into cells of spleen, liver and kidney of mice. Chemotherapy (1986) 0.86
Complexes of DNA hairpins and a single-stranded oligonucleotide detected by affinity chromatography and mung bean nuclease cleavage. Eur J Biochem (1987) 0.85
Evolution of a genetic code simulated with the computer. Orig Life (1978) 0.85
Probing the substrate alignment at the active site of 15-lipoxygenases by targeted substrate modification and site-directed mutagenesis. Evidence for an inverse substrate orientation. Biochemistry (1998) 0.85
Computer model of the formation of self-organizing systems. Angew Chem Int Ed Engl (1972) 0.84
Angiogenic markers in breath condensate identify non-small cell lung cancer. Lung Cancer (2009) 0.84
[Sagittal burst fracture of the talus]. Radiologe (1994) 0.84
Structural basis for pH-dependent alterations of reaction specificity of vertebrate lipoxygenase isoforms. Biochim Biophys Acta (2009) 0.84
Effect of transcoronary ablation of septal hypertrophy on clinical outcome in hypertrophic obstructive cardiomyopathy associated with atrial fibrillation. Clin Res Cardiol (2006) 0.83
Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens (1989) 0.83
[Light and electron microscopy findings in early and late stages of heart failure. Studies of endomyocardial biopsies of patients with latent (LCM) and dilated (DCM) cardiomyopathy]. Z Kardiol (1985) 0.83
Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction. ALKK Study Group. Am J Cardiol (1997) 0.83
[Photic stretching on bimolecular lipid-pigment membranes]. Z Naturforsch B (1969) 0.83
Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries. Arterioscler Thromb Vasc Biol (1995) 0.83
[Congestive cardiomyopathy]. Med Welt (1973) 0.82
An artificial primosome: design, function, and applications. Chembiochem (2001) 0.82
Oxygenation of biomembranes by mammalian lipoxygenases: the role of ubiquinone. Free Radic Biol Med (1996) 0.82
[Chemistry, structure and origin of carotene crystals in the secondary corona of Narcissus poeticus L. var. 'La Riante']. J Ultrastruct Res (1970) 0.81
Alterations of lipoxygenase specificity by targeted substrate modification and site-directed mutagenesis. Chem Biol (2001) 0.81
Lack of correlation between melanin affinity and retinopathy in mice and cats treated with chloroquine or flunitrazepam. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1981) 0.81
Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Z Kardiol (2002) 0.81
Dialysis bone disease. Isr J Med Sci (1971) 0.80
Growth and stability of thrombi in flowing citrated blood: assessment of platelet-surface interactions with computer-assisted morphometry. Thromb Haemost (1988) 0.80
A simple method for the preparation of cell cultures for ultrastructural investigation. J Histochem Cytochem (1981) 0.79
Degeneration and regeneration of adrenergic nerves in mesenteric blood vessels, iris and atrium of the rat after 6-hydroxydopamine injection. J Neurocytol (1975) 0.79
Effects of cilazapril on the cerebral circulation in spontaneously hypertensive rats. Hypertension (1989) 0.79
Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way. Biochem Pharmacol (2004) 0.78
Disk formation in retinal cones of Tupaia belangeri (Scandentia). Cell Tissue Res (1998) 0.78
[Determination of systolic time intervals. A non-invasive method for evaluation of left ventricle function]. Dtsch Med Wochenschr (1980) 0.78
[Left bundle-branch block: inferences from ventricular septal motion in the echocardiogram concerning left ventricular function]. Z Kardiol (1983) 0.78
Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog. J Pharmacol Exp Ther (1993) 0.78
The adrenergic innervation of the renal artery and vein of the rat. A fluorescence histochemical and electron microscopical study. Z Zellforsch Mikrosk Anat (1973) 0.78
Alterations in leukotriene synthase activity of the human 5-lipoxygenase by site-directed mutagenesis affecting its positional specificity. Biochemistry (2000) 0.78
[Expired diagnosis?--the potential of exhaled breath analysis]. Pneumologie (2004) 0.78
The role of the low density lipoprotein receptor for alpha-tocopherol delivery to tissues. Ann N Y Acad Sci (1989) 0.78
Bacterial and nonbacterial expression of wild-type and mutant human phospholipid hydroperoxide glutathione peroxidase and purification of the mutant enzyme in the milligram scale. Protein Expr Purif (2000) 0.78
Decreased coronary vascular reserve in Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis (1988) 0.78
The earliest invasion of macrophages into the developing brain and eye of the tree shrew Tupaia belangeri. Anat Embryol (Berl) (1999) 0.78
The effect of tetraethylammonium chloride on calcium fluxes in smooth muscle from rabbit main pulmonary artery. J Physiol (1980) 0.78
An ultrastructural investigation of the effects of perinatal malnutrition on E-PTA-stained synaptic junctions. Experientia (1975) 0.77
[Glycolytic energy concentration in the hypoxemic myocardium]. Med Welt (1974) 0.77
Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol (2000) 0.77
Determinants of umbilical cord arterial 8-iso-prostaglandin F2alpha concentrations. BJOG (2000) 0.77
[Energy metabolism in hypoxic myocardium]. Verh Dtsch Ges Inn Med (1973) 0.77
Serotonin organelles of rabbit platelets contain synaptophysin. Eur J Biochem (1990) 0.77
Orthotopic implantation of inflamed synovial tissue from RA patients induces a characteristic arthritis in immunodeficient (SCID) mice. J Autoimmun (1996) 0.77
[Behavior of catecholamines and of cyclic 3'5'-AMP in plasma of normal persons under the effect of a beta-receptor blockader]. Verh Dtsch Ges Kreislaufforsch (1974) 0.77
Procoagulant activity of endotoxin-treated human endothelial cells exposed to native human flowing blood. Blood (1989) 0.77
PNA openers as a tool for direct quantification of specific targets in duplex DNA. J Biomol Struct Dyn (1999) 0.76
Effects of chronic aortic coarctation on atherosclerosis and arterial lipid accumulation in the Watanabe hereditary hyperlipidemic (WHHL) rabbit. Atherosclerosis (1992) 0.76